Floatz logo

Therapeutic Asset Ratings

297 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Irinotecan
Endometrial Serous Adenocarcinoma
Roswell Park Cancer InstituteP2BB (64)
Pembrolizumab
Richter Syndrome
Roswell Park Cancer InstituteP2BB (64)
Rapamycin
Recurrent Adult Acute Lymphoblastic Leukemia
Roswell Park Cancer InstituteP2BB (64)
TESTOSTERONE CIPIONATE
Castration-Resistant Prostate Carcinoma
Roswell Park Cancer InstituteP2BB (64)
Cyclophosphamide
Fallopian Tube Endometrioid Adenocarcinoma
Roswell Park Cancer InstituteP2B (63)
Cyclophosphamide
Primary Peritoneal Serous Adenocarcinoma
Roswell Park Cancer InstituteP2B (63)
Epirubicin
Fallopian Tube Serous Adenocarcinoma
Roswell Park Cancer InstituteP2B (63)
Epirubicin
Ovarian Clear Cell Adenocarcinoma
Roswell Park Cancer InstituteP2B (63)
Epirubicin
Primary Peritoneal Serous Adenocarcinoma
Roswell Park Cancer InstituteP2B (63)
Evomela
Acute Myeloid Leukemia in Remission
Roswell Park Cancer InstituteP2B (63)
Evomela
Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Roswell Park Cancer InstituteP2B (63)
Montanide Isa 51
Stage III Lung Cancer AJCC v8
Roswell Park Cancer InstituteP2B (63)
Pembrolizumab
Fallopian Tube Serous Adenocarcinoma
Roswell Park Cancer InstituteP2B (63)
Pembrolizumab
Ovarian Clear Cell Adenocarcinoma
Roswell Park Cancer InstituteP2B (63)
Pembrolizumab
Ovarian Serous Adenocarcinoma
Roswell Park Cancer InstituteP2B (63)
Pembrolizumab
Primary Peritoneal Serous Adenocarcinoma
Roswell Park Cancer InstituteP2B (63)
(+)-VINCRISTINE
Endometrial Serous Adenocarcinoma
Roswell Park Cancer InstituteP2B (63)
Photofrin II
Non-Small Cell Lung Carcinoma
Roswell Park Cancer InstituteP1/2B (63)
Cediranib
Clear Cell Renal Cell Carcinoma
Roswell Park Cancer InstituteP3B (62)
Pembrolizumab
Epithelial Ovarian Cancer
Roswell Park Cancer InstituteP3B (62)
Cyclophosphamide
Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
Roswell Park Cancer InstituteP2B (62)
Evomela
Waldenstrom Macroglobulinemia
Roswell Park Cancer InstituteP2B (62)
Irinotecan
Recurrent Primary Peritoneal Endometrioid Adenocarcinoma
Roswell Park Cancer InstituteP2/3B (62)
(+)-VINCRISTINE
Recurrent Primary Peritoneal Endometrioid Adenocarcinoma
Roswell Park Cancer InstituteP2/3B (62)
TESTOSTERONE UNDECYLATE
Prostate Cancer
Roswell Park Cancer InstituteP4B (61)
Showing 51 to 75 of 297 assets
PreviousPage 3 of 12Next